Literature DB >> 7935809

DNA repair. Incisions for excision.

J H Hoeijmakers, D Bootsma.   

Abstract

Mesh：

Year:  1994        PMID： 7935809     DOI： 10.1038/371654a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

Review 1.  Refining the treatment of advanced nonsmall cell lung cancer.

Authors:  Shin Ogita; Antoinette J Wozniak
Journal:  Lung Cancer (Auckl)       Date:  2010-05-03

2.  Evidence for at least eight Fanconi anemia genes.

Authors:  H Joenje; A B Oostra; M Wijker; F M di Summa; C G van Berkel; M A Rooimans; W Ebell; M van Weel; J C Pronk; M Buchwald; F Arwert
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

3.  An alternative eukaryotic DNA excision repair pathway.

Authors:  G A Freyer; S Davey; J V Ferrer; A M Martin; D Beach; P W Doetsch
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

4.  Deficient DNA repair capacity, a predisposing factor in breast cancer.

Authors:  R Parshad; F M Price; V A Bohr; K H Cowans; J A Zujewski; K K Sanford
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

5.  In TFIIH, XPD helicase is exclusively devoted to DNA repair.

Authors:  Jochen Kuper; Cathy Braun; Agnes Elias; Gudrun Michels; Florian Sauer; Dominik R Schmitt; Arnaud Poterszman; Jean-Marc Egly; Caroline Kisker
Journal:  PLoS Biol       Date:  2014-09-30       Impact factor: 8.029

Review 6.  Novel therapeutic strategies in the treatment of triple-negative breast cancer.

Authors:  Karima Oualla; Heba M El-Zawahry; Banu Arun; James M Reuben; Wendy A Woodward; Heba Gamal El-Din; Bora Lim; Nawfel Mellas; Naoto T Ueno; Tamer M Fouad
Journal:  Ther Adv Med Oncol       Date:  2017-06-13       Impact factor: 8.168

7.  Triple-negative breast cancer: treatment challenges and solutions.

Authors:  Joëlle Collignon; Laurence Lousberg; Hélène Schroeder; Guy Jerusalem
Journal:  Breast Cancer (Dove Med Press)       Date:  2016-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.